Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isolation and characterization of monoclonal antibodies from recovered Lassa fever patients
NL-OMON53355Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2023
- Countries
- 1
01
Overview
Open-label, single-arm trial in Lassa fever and Viral Haemorrhagic Fevers (VHF), sponsored by Amsterdam University Medical Center. Primary endpoint: Neutralization potency and breadth of derived monoclonal antibodies. Started Jul 2023; status: recruiting.
02
Conditions
Lassa feverViral Haemorrhagic Fevers (VHF)
Beyond the preview
Go deeper on NL-OMON53355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON53355.